Outsourcing to CMOs in Emerging EconomiesBoon or Bane?

Outsourcing to CMOs in Emerging EconomiesBoon or Bane?

Analyzing the Prospects of CMOs in Emerging Markets

RELEASE DATE
30-Apr-2013
REGION
Global
Research Code: 9837-00-54-00-00
SKU: LS00065-GL-MR_16906
AvailableYesPDF Download
$1,500.00
In stock
SKU
LS00065-GL-MR_16906
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This article provides an outlook of the key trends which impact the global pharmaceutical and biotech contract manufacturing markets and analyses the pros and cons of outsourcing manufacturing processes to contract manufacturing organisations (CMOs) in emerging markets. Strategic recommendations for the success of CMOs have also been provided.

Table of Contents

Outsourcing to CMOs in Emerging Markets—Opportunities and Challenges

This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.
More Information
No Index Yes
Podcast No
Author Aiswariya Chidambaram
WIP Number 9837-00-54-00-00
Is Prebook No